Home・Akciju saraksts・Quanterix Corp

Quanterix Corp

Slēgts

SektorsVeselības aprūpe

4.01 4.97

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

3.82

Max

4.03

Galvenie mērījumi
By Trading Economics
Ienākumi	5.6M -18M
Pārdošana	-7.4M 36M
EPS	0.16
Peļņas marža	-48.17
Darbinieki	450
EBITDA	5.5M -11M

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	+4.44% upside

Dividendes
By Acuity
Nākamie ieņēmumi	2026. g. 10. aug.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	16M 175M
Iepriekšējā atvēršanas cena	-0.96
Iepriekšējā slēgšanas cena	4.01

Ziņu noskaņojums

By Acuity

50%

168 / 340 Rangs Healthcare

Quanterix Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 5. aug. 19:23 UTC

Quanterix Corp shares are higher, supported by a broader rise in the Life Sciences Tools & Services sector. The stock remains below its 20-day moving average.

2026. g. 3. aug. 19:26 UTC

Quanterix Corp shares are higher today, tracking broader market gains amid rising confidence in tech stocks and falling energy prices.

2026. g. 31. jūl. 19:46 UTC

Quanterix Corp shares are higher today, reflecting a modest gain since Thursday's close. The stock is near the lower end of its one-month range.

2026. g. 30. jūl. 19:59 UTC

Quanterix Corp is trading higher amid a broader recovery in tech shares. The asset has shown notable volatility, pulling back from earlier session highs.

2026. g. 29. jūl. 19:43 UTC

Macro Event

Quanterix Corp's shares are lower today amid broader market declines, reflecting heightened volatility following the Federal Reserve's decision to maintain interest rates.

2026. g. 28. jūl. 20:06 UTC

Quanterix Corp shares are declining amid broader market weakness, with the Nikkei 225 dropping significantly due to concerns over AI spending and semiconductor competition.

2026. g. 27. jūl. 16:06 UTC

Quanterix Corp shares are higher today, following a strong opening. No specific news was identified to explain the price movement.

2026. g. 24. jūl. 19:53 UTC

Quanterix Corp shares are lower today, continuing a decline since Thursday amid broader market uncertainty from oil volatility and new U.S. tariffs.

2026. g. 22. jūl. 19:36 UTC

Quanterix Corp shares are lower in Wednesday's session, continuing a decline since Tuesday's close amid rising crude oil prices and market concerns.

2026. g. 21. jūl. 21:26 UTC

Quanterix Corp shares are higher in after-market hours, reflecting positive trading momentum. Broader market strength may be influencing sentiment following the close.

2026. g. 20. jūl. 19:46 UTC

Quanterix Corp shares are higher today amid positive market sentiment and a notable rise in the Hang Seng 50 Index, despite no specific company news.

Salīdzinājums

Cenas izmaiņa

Quanterix Corp Prognoze

Cenas mērķis

By TipRanks

4.44% augšup

Prognoze 12 mēnešiem

Vidējais 4 USD 4.44%

Augstākais 4 USD

Zemākais 4 USD

Pamatojoties uz 1 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Quanterix Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

1 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 1 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Quanterix Corp — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

168 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.